These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 19209028

  • 1. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

  • 2. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK, Agarwal C, Chan DC, Agarwal R.
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 4. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ, Liu ZJ, Shimoi K, Zhu BT.
    Cancer Res; 2005 Jan 15; 65(2):387-93. PubMed ID: 15695378
    [Abstract] [Full Text] [Related]

  • 5. Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.
    Wigington DP, Urben CM, Strugnell SA, Knutson JC.
    Anticancer Res; 2004 Jan 15; 24(5A):2905-12. PubMed ID: 15517895
    [Abstract] [Full Text] [Related]

  • 6. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K, Kaminski R, Legat M, Kopec M, Nowis D, Skierski JS, Koronkiewicz M, Jakóbisiak M, Golab J.
    Int J Oncol; 2004 May 15; 24(5):1149-57. PubMed ID: 15067336
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M, Hsu S, Lewis G, Pietras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, Slamon D.
    Oncogene; 1999 Apr 01; 18(13):2241-51. PubMed ID: 10327070
    [Abstract] [Full Text] [Related]

  • 8. Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells.
    Liebmann JE, Fisher J, Teague D, Cook JA.
    Oncol Res; 1994 Apr 01; 6(1):25-31. PubMed ID: 7919549
    [Abstract] [Full Text] [Related]

  • 9. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R.
    Cancer Res; 2000 Apr 01; 60(7):2040-8. PubMed ID: 10766196
    [Abstract] [Full Text] [Related]

  • 10. Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro.
    Yerushalmi R, Nordenberg J, Beery E, Uziel O, Lahav M, Luria D, Fenig E.
    Exp Oncol; 2007 Jun 01; 29(2):126-31. PubMed ID: 17704745
    [Abstract] [Full Text] [Related]

  • 11. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J, Lopez JP, Altuna X, Chu TS, Weisman RA, Ongkeko WM.
    Laryngoscope; 2006 Aug 01; 116(8):1409-16. PubMed ID: 16885745
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH.
    Cancer Res; 2005 Aug 01; 65(15):6934-42. PubMed ID: 16061678
    [Abstract] [Full Text] [Related]

  • 13. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S, Schittenhelm M, Honecker F, Malenke E, Lauber K, Wesselborg S, Hartmann JT, Bokemeyer C, Mayer F.
    Int J Oncol; 2006 Aug 01; 29(2):471-9. PubMed ID: 16820891
    [Abstract] [Full Text] [Related]

  • 14. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ, Cheung RY, Manias J, Connor A, Rauth AM, Wu XY.
    Breast Cancer Res Treat; 2010 Jan 01; 119(2):255-69. PubMed ID: 19221875
    [Abstract] [Full Text] [Related]

  • 15. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models.
    Mewani RR, Tang W, Rahman A, Dritschilo A, Ahmad I, Kasid UN, Gokhale PC.
    Int J Oncol; 2004 May 01; 24(5):1181-8. PubMed ID: 15067340
    [Abstract] [Full Text] [Related]

  • 16. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
    Tanaka R, Takii Y, Shibata Y, Ariyama H, Qin B, Baba E, Kusaba H, Mitsugi K, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2005 Sep 01; 56(3):279-85. PubMed ID: 15875187
    [Abstract] [Full Text] [Related]

  • 17. Combination effects of SC144 and cytotoxic anticancer agents.
    Oshima T, Cao X, Grande F, Yamada R, Garofalo A, Louie S, Neamati N.
    Anticancer Drugs; 2009 Jun 01; 20(5):312-20. PubMed ID: 19322070
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
    Adjei AA, Budihardjo II, Rowinsky EK, Kottke TJ, Svingen PA, Buckwalter CA, Grochow LB, Donehower RC, Kaufmann SH.
    Clin Cancer Res; 1997 May 01; 3(5):761-70. PubMed ID: 9815747
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines.
    Supiot S, Gouard S, Charrier J, Apostolidis C, Chatal JF, Barbet J, Davodeau F, Cherel M.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7047s-7052s. PubMed ID: 16203801
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P, Wang MM, Jiang LY, Liu HT, Sun JZ.
    Chin Med J (Engl); 2008 Oct 20; 121(20):1975-9. PubMed ID: 19080259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.